A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Completed · Phase 2/Phase 3

Conditions studied: Alzheimer's Disease

In brief

The purpose of this study is to evaluate the changes in the cognitive, functional, behavioral and global domains based on the different applicable psychometric batteries and scales.

Key facts

Study ID
NCT01561053
Run by
Instituto Grifols, S.A.
People needed
347
Starts
2012-04-19
Expected to finish
2018-03-06
Last updated by the study team
2019-07-31

Who can join

Age: 55 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.